Dublin, 16 August 2023 (Globe Newswire) — “Heart-lung Machine Market Size, Share and Trend Analysis Report, By Component (oxygenator, pump, cannula), By Application, By End-use (Hospital, Cardiac Center), By Region, Segment Forecast, 2023-2030” report added of ResearchAndMarkets.com Recruitment.
The global cardiopulmonary bypass market is expected to reach USD 3.66 billion by 2030. The market is expected to expand at a CAGR of 6.9% from 2023 to 2030. A heart-lung machine (CPB) machine is also known as a heart-lung machine. This machine plays an important role in open heart surgery, including procedures to address cardiovascular disease (CVD). It temporarily takes over the functions of the heart and lungs, allowing the surgeon to operate on a still heart while maintaining blood circulation and oxygenation.
According to the World Health Organization (WHO), CVD is one of the leading causes of mortality worldwide, killing an estimated 17.9 million people annually. Heart disease is the leading cause of death for both men and women in the United States. Additionally, the high prevalence of heart disease has increased the demand for a wide range of cardiovascular surgeries such as thoracotomy, with approximately 500,000 procedures performed annually. The cardiopulmonary bypass (CPB) machine market is growing due to increasing number of cardiovascular surgeries and advances in surgical technique and technology. As a result, the CPB machine market is growing due to its important role in cardiac surgery.
Heart Lung Machines Market Report Highlights
- In 2022, the oxygenator segment accounted for 25.87% of the CPB machine market, accounting for the largest share. Oxygenators are important components in CPB procedures as they help remove carbon dioxide and add oxygen to the blood, effectively performing the respiratory function of the lungs.
- In 2022, the coronary artery bypass graft (CABG) segment accounted for 31.07% of the CPB machine market, accounting for the largest share. Prevalence of CVD and Rising Demand for Bypass Surgery Drive CABG Segment Growth
- In 2022, the hospital segment will hold the largest share of the CPB machine market with 81.07%. This dominance is driven by factors such as the increasing prevalence of CVD, advances in surgical procedures, and increasing demand for cardiac surgery. In addition, aging population is more susceptible to valvular heart disease and other cardiovascular diseases, thus playing an important role in the growth of the market.
- In 2022, North America held a dominant share of 41.62% in the CPB machine market. This large market share is mainly due to factors such as high incidence of heart disease, sizable aging population and strong medical infrastructure.These factors collectively contributed to growth in the North America region
companies mentioned
- medtronic
- Terumo Europe NV
- Livanova Co., Ltd.
- Getinge
- brail biomedica
- Nipro
- Tianjin Welcome Medical Equipment Co., Ltd.
- elite life care
- Hemovent
- MERA (Senko Medical Device Manufacturing Co., Ltd.)
- Techno Wood International Pte.
Key Attributes:
| report attribute | detail |
| number of pages | 100 |
| Forecast period | 2022-2030 |
| 2022 Estimated Market Value (USD) | $2.18 billion |
| Projected market value (USD) to 2030 | $3.66 billion |
| compound annual growth rate | 6.9% |
| Target area | global |
For more information on this report, please visit: https://www.researchandmarkets.com/r/j7zy8l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.
